SBI-581 is an orally active, potent selective inhibitor of serine-threonine kinase TAO3, with an IC 50 of 42 nM. It effectively promotes the accumulation of TKS5alpha at RAB11-positive vesicles and inhibits the formation of invadopodia. Additionally, SBI-581 exhibits reasonable pharmacokinetics in mice when administered via IP injection, demonstrating significant antitumor activity [1].
Molecular Weight:
383.44
Formula:
C24H21N3O2
Target:
Others|||Serine Protease
* VAT and and shipping costs not included. Errors and price changes excepted
